Exelixis EXEL Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Exelixis in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exelixis's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exelixis's operating income?
- Exelixis (EXEL) reported operating income of $251.34M in Q1 2026.
- How has Exelixis's operating income changed year-over-year?
- Exelixis's operating income increased by 34.5% year-over-year, from $186.86M to $251.34M.
- What is the long-term trend for Exelixis's operating income?
- Over 3 years (2021 to 2025), Exelixis's operating income has grown at a 44.9% compound annual growth rate (CAGR), from $286.67M to $872.19M.
- What does operating income mean?
- Profit earned from core business operations before interest and taxes.
- How do you interpret operating income?
- Higher operating income indicates strong operational efficiency and successful commercialization of products.
- How does operating income compare across companies?
- The primary metric for comparing operational performance across the biopharma industry.